
Sunshine Health is owned by Centene Corporation (NYSE: CNC), a publicly traded American managed care company headquartered in St. Louis, Missouri. Sunshine Health is Centene's Florida-based health insurance brand, providing Medicaid managed care, Long Term Care, Ambetter health insurance marketplace plans, and Medicare Advantage plans to Florida residents. Sunshine Health is among the largest comprehensive healthcare plans in Florida. Following Centene's $17.3 billion acquisition of WellCare Health Plans in January 2020, WellCare of Florida's Medicare Advantage operations were integrated into the Sunshine Health umbrella in Florida.
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Sunshine Health | Centene Corporation | Wholly owned |
Sunshine Health was established in 2008 by Centene Corporation as the company's Florida-focused health insurance brand. Centene created Sunshine Health to enter Florida's Medicaid managed care market, which is one of the largest state Medicaid markets in the United States given Florida's large and growing population.
Centene's entry into Florida's Medicaid market through Sunshine Health was part of the company's broader strategy of expanding its Medicaid managed care operations across multiple states. Centene had developed expertise in managing Medicaid populations in other states and applied this expertise to the Florida market. The brand was designed to reflect Florida's identity and appeal to Florida's diverse Medicaid population.
Sunshine Health expanded its membership throughout the 2010s as Florida's Medicaid managed care program grew. Florida transitioned its Medicaid program to a managed care model, requiring most Medicaid beneficiaries to enroll in managed care plans. This transition significantly expanded the market for Medicaid managed care plans in Florida and provided growth opportunities for Sunshine Health.
In addition to Medicaid managed care, Sunshine Health expanded into the Affordable Care Act health insurance marketplace in Florida, offering plans under the Ambetter brand. Ambetter is Centene's national marketplace brand, and Sunshine Health operates Ambetter plans in Florida, providing health insurance marketplace coverage to individuals and families who purchase insurance through the federal marketplace.
The most significant development in Sunshine Health's history was Centene's $17.3 billion acquisition of WellCare Health Plans, which completed in January 2020. WellCare was a major competitor to Sunshine Health in Florida's Medicaid market, operating WellCare of Florida as a separate Medicaid managed care plan. The acquisition combined Centene's Sunshine Health and WellCare's Florida operations under Centene's ownership, significantly expanding Centene's Florida membership and market position.
Following the WellCare acquisition, Centene integrated WellCare's Florida operations into the Sunshine Health organizational structure. WellCare of Florida's Medicare Advantage plans continued to operate under the WellCare brand name, while Medicaid operations were consolidated under Sunshine Health. This integration made Sunshine Health one of the most comprehensive health plan operators in Florida, with coverage across Medicaid, Long Term Care, marketplace, and Medicare Advantage programs.
Through 2025 and into 2026, Sunshine Health has continued to serve hundreds of thousands of members across Florida. The brand's growth has been driven by Florida's expanding population, increasing Medicaid enrollment, and growing demand for Affordable Care Act marketplace plans. However, Centene has faced broader challenges including declining Medicaid enrollment following the end of continuous Medicaid enrollment requirements during the COVID-19 pandemic, which affected membership across its state plans.
Is Centene a subsidiary of another company?
No, Centene Corporation is an independent, publicly traded corporation with no parent company. The company operates independently with its own management structure and board of directors, though it has grown through numerous acquisitions throughout its history, including the transformative $17.3 billion acquisition of WellCare Health Plans in January 2020.
Is Centene publicly traded?
Yes, Centene Corporation is publicly traded on the New York Stock Exchange under the ticker symbol CNC. The company has been publicly traded since its IPO in 2001, when it had three health plans, $327 million in revenue, and 235,000 members. As of 2025, the company is ranked No. 23 on the Fortune 500 list.
When was Centene founded?
Centene traces its origins to 1984 when Elizabeth Brinn founded Managed Health Services as a non profit organization in Milwaukee, Wisconsin. The company was renamed Centene Corporation in 1997 when Michael Neidorff was named President and CEO, and the corporate office was established in St. Louis, Missouri. The company went public in 2001.
Who founded Centene?
Centene was founded by Elizabeth Brinn in 1984 as Managed Health Services, a non profit organization focused on providing healthcare services to Medicaid populations in Milwaukee, Wisconsin. After her death, the organization was converted to a for profit company. Michael Neidorff was named CEO in 1997 and grew Centene from a local health plan to a national healthcare leader over 25 years.
What is Centene's annual revenue?
For fiscal year 2025 (ended December 31, 2025), Centene reported total revenue of $194.8 billion, a 19% increase from $163.1 billion in FY2024. Premium and service revenues were $174.6 billion, up 20% year over year. The company recorded a GAAP net loss of $6.7 billion, primarily due to a $6.7 billion non cash goodwill impairment charge. Adjusted diluted EPS was $2.08, down from $7.17 in FY2024.
What is Centene's market position?
Centene is the largest Medicaid managed care organization in the United States, the longest running carrier in the Health Insurance Marketplace, and a national leader in Medicare Prescription Drug Plans. The company serves 27.6 million members across all 50 states as of December 31, 2025, with revenue from Medicaid (57%), Commercial (21%), Medicare (19%), and Other (3%) segments. Centene is ranked No. 23 on the Fortune 500 and No. 42 on the Fortune Global 500.
Who is Centene's CEO?
Sarah M. London has served as Chief Executive Officer of Centene Corporation since 2022. She is the first woman to lead the company. Under her leadership, Centene has refocused on three core lines of business: Medicaid, Medicare, and the Health Insurance Marketplace. In 2025, London navigated the company through significant challenges including the $6.7 billion goodwill impairment, Marketplace risk adjustment shortfall, and elevated Medicaid medical cost trends.
What is the WellCare acquisition?
In January 2020, Centene completed the acquisition of WellCare Health Plans in a $17.3 billion transaction (enterprise value). WellCare shareholders received 3.38 shares of Centene common stock and $120 in cash for each share of WellCare common stock. The acquisition made Centene a nationwide company serving all 50 states with approximately 24 million members, expanded its Medicare platform, and extended its Medicaid offerings. WellCare became a wholly owned subsidiary of Centene and continues to operate as a brand under the Centene umbrella.
Sunshine Health operates under Centene Corporation's sustainability framework. Centene publishes an annual sustainability report addressing environmental responsibility, social impact, and governance across its operations. The report covers healthcare accessibility, community health improvement, and environmental stewardship.
Sunshine Health's primary sustainability focus is healthcare accessibility and equity across Florida's diverse communities. The company provides Medicaid managed care services to eligible Florida residents, including vulnerable populations and underserved communities. Sunshine Health addresses social determinants of health by connecting members with community resources for housing, food security, and transportation to medical appointments.
Centene has set environmental goals including reducing carbon emissions from office operations. Sunshine Health's Florida facilities participate in these initiatives through energy-efficient building systems, telehealth services that reduce transportation emissions, and waste reduction programs.
Centene maintains supplier diversity programs and community investment initiatives. The company reports on its environmental, social, and governance performance in its annual sustainability report, available on Centene's corporate website.
Sunshine Health operates in a highly regulated environment and has faced challenges typical of large Medicaid managed care organizations.
Centene Corporation has faced regulatory scrutiny and legal challenges related to its Medicaid managed care operations. In 2021, Centene agreed to pay $15.2 million to the state of Ohio to resolve allegations of overcharging the state's Medicaid program for pharmacy services. In 2023, Centene agreed to pay $166 million to the state of Texas to resolve similar pharmacy benefit management allegations. These settlements raised questions about Centene's pharmacy benefit management practices across its state Medicaid contracts, including Florida.
Sunshine Health faces ongoing competition for Florida Medicaid managed care contracts through periodic bidding processes administered by AHCA. The company must continuously demonstrate value on quality metrics and cost-effectiveness to maintain its contracts. Losing a Medicaid contract in a competitive rebidding process could significantly impact Sunshine Health's membership and revenue.
The integration of WellCare of Florida's Medicare Advantage operations following Centene's 2020 acquisition created operational challenges. The company had to harmonize different operational systems and approaches while maintaining service continuity for Medicare Advantage members.
Sunshine Health operates in a politically sensitive environment where healthcare policy changes, Medicaid funding levels, and regulatory requirements can significantly impact operations. The end of continuous Medicaid enrollment requirements following the COVID-19 pandemic led to membership losses across Centene's state plans, including Florida, as eligible members were redetermined and some lost coverage.
Provider network management remains an ongoing challenge. Sunshine Health must maintain adequate provider networks across all Florida regions, negotiate fair reimbursement rates with healthcare providers, and ensure member access to care, particularly in rural areas of the state.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Centene | USA | 1985 | Mass market | United states | All-ages |
Market Positioning: Sunshine Health competes with 1 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by Centene Corporation, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by Herbalife Ltd.
Global nutrition and weight-management brand owned by Herbalife Ltd. and sold through independent distributors in more than 90 markets.
Herbalife operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Chempro Chemists
Australian online pharmacy operated by Chempro Chemists from Molendinar, Queensland. Offers prescription medications, health products, and wellness items through digital platforms and mail-order delivery.
Pharmacy Direct is privately owned, unlike Sunshine Health which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Alcon Inc.
Independent publicly traded global eye care company headquartered in Geneva, Switzerland, specializing in surgical equipment, contact lenses, and ophthalmic products. Spun off from Novartis in April 2019.
Alcon operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by GE HealthCare Technologies Inc.
Independent publicly traded healthcare technology company spun off from General Electric in January 2023, providing medical imaging, diagnostics, and healthcare IT solutions globally.
GE HealthCare operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by GoodRx Holdings, Inc.
American healthcare technology platform providing prescription drug price comparison, discount coupons, and telehealth services to help consumers find affordable healthcare options.
GoodRx operates independently without a large parent corporation.
Owned by Menicon Co., Ltd.
Japan's first and largest contact lens manufacturer, founded in 1951 in Nagoya. Known for rigid gas permeable lenses, orthokeratology, and expanding daily disposable silicone hydrogel products.
Menicon operates independently without a large parent corporation.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.

Activase (alteplase) is a prescription thrombolytic medication manufactured by Genentech, a wholly-owned subsidiary of Roche. Used to treat acute ischemic stroke, heart attack, and pulmonary embolism.